Urovo Technology Bilan de santé
Santé financière contrôle des critères 5/6
Urovo Technology has a total shareholder equity of CN¥1.5B and total debt of CN¥582.5M, which brings its debt-to-equity ratio to 38.7%. Its total assets and total liabilities are CN¥2.3B and CN¥827.0M respectively. Urovo Technology's EBIT is CN¥50.2M making its interest coverage ratio -7.3. It has cash and short-term investments of CN¥1.2B.
Informations clés
38.7%
Ratio d'endettement
CN¥582.53m
Dette
| Ratio de couverture des intérêts | -7.3x |
| Argent liquide | CN¥1.17b |
| Fonds propres | CN¥1.51b |
| Total du passif | CN¥827.05m |
| Total des actifs | CN¥2.33b |
Mises à jour récentes de la santé financière
Recent updates
Urovo Technology Co., Ltd.'s (SZSE:300531) Shares Climb 59% But Its Business Is Yet to Catch Up
Oct 08
Is Urovo Technology (SZSE:300531) A Risky Investment?
Sep 27Optimistic Investors Push Urovo Technology Co., Ltd. (SZSE:300531) Shares Up 45% But Growth Is Lacking
Aug 23Urovo Technology (SZSE:300531) Will Want To Turn Around Its Return Trends
Jul 25Urovo Technology's (SZSE:300531) Dividend Will Be CN¥0.05
May 26Calculating The Intrinsic Value Of Urovo Technology Co., Ltd. (SZSE:300531)
Mar 27Urovo Technology Co., Ltd.'s (SZSE:300531) 27% Price Boost Is Out Of Tune With Earnings
Mar 06Capital Allocation Trends At Urovo Technology (SZSE:300531) Aren't Ideal
Feb 28Analyse de la situation financière
Passif à court terme: 300531's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥795.0M).
Passif à long terme: 300531's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥32.1M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 300531 has more cash than its total debt.
Réduire la dette: 300531's debt to equity ratio has increased from 22.9% to 38.7% over the past 5 years.
Couverture de la dette: 300531's debt is well covered by operating cash flow (27.9%).
Couverture des intérêts: 300531 earns more interest than it pays, so coverage of interest payments is not a concern.